}

Sabaa Pharmaceutical logs EGP 2,910 in profits in H1 2026

Updated 8/12/2026 11:07:00 AM
Sabaa Pharmaceutical logs EGP 2,910 in profits in H1 2026

Arab Finance: Sabaa International for Pharmaceutical and Chemical Industry (SIPC) generated net profits after tax worth EGP 2,910 in the first half (H1) of 2026, down from EGP 11.933 million in the same period a year earlier, as per the financial results.

Revenues decreased to EGP 15.758 million from EGP 25.373 million.

Established in 2000, Sabaa International Company for Pharmaceutical and Chemical is specialized in manufacturing generic medicine and pharmaceuticals. Sabaa has been registered on the EGX since 2013.

 

 

Related News